Shandong Jincheng Pharmaceutical Group Co., Ltd
300233.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥4,551,984 | CN¥6,395,358 | CN¥8,766,951 | CN¥11,218,762 |
| - Cash | CN¥917,671 | CN¥1,024,635 | CN¥859,028 | CN¥981,084 |
| + Debt | CN¥413,917 | CN¥444,159 | CN¥650,911 | CN¥652,625 |
| Enterprise Value | CN¥4,048,230 | CN¥5,814,882 | CN¥8,558,834 | CN¥10,890,303 |
| Revenue | CN¥3,373,387 | CN¥3,538,312 | CN¥3,505,717 | CN¥3,138,454 |
| % Growth | -4.7% | 0.9% | 11.7% | – |
| Gross Profit | CN¥1,353,788 | CN¥1,464,919 | CN¥1,620,461 | CN¥1,651,337 |
| % Margin | 40.1% | 41.4% | 46.2% | 52.6% |
| EBITDA | CN¥606,187 | CN¥564,015 | CN¥628,555 | CN¥447,612 |
| % Margin | 18% | 15.9% | 17.9% | 14.3% |
| Net Income | CN¥196,781 | CN¥174,709 | CN¥273,365 | CN¥107,984 |
| % Margin | 5.8% | 4.9% | 7.8% | 3.4% |
| EPS Diluted | 0.52 | 0.46 | 0.71 | 0.28 |
| % Growth | 13% | -35.2% | 153.6% | – |
| Operating Cash Flow | CN¥296,586 | CN¥664,075 | CN¥255,627 | CN¥437,185 |
| Capital Expenditures | -CN¥142,614 | -CN¥342,899 | -CN¥373,668 | -CN¥376,145 |
| Free Cash Flow | CN¥153,972 | CN¥321,176 | -CN¥118,042 | CN¥61,041 |